Time to recurrence, but not recurrence-free survival, should be the endpoint used to predict early recurrence after HCC resection

J Hepatol. 2019 Mar;70(3):570-571. doi: 10.1016/j.jhep.2018.10.025. Epub 2018 Dec 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / surgery*
  • Disease-Free Survival
  • Hepatectomy
  • Humans
  • Liver Neoplasms / surgery*
  • Neoplasm Recurrence, Local / surgery